Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients
- 31 March 1991
- journal article
- other
- Published by Elsevier in Psychiatry Research
- Vol. 36 (3) , 333-335
- https://doi.org/10.1016/0165-1781(91)90032-k
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Treatment of Resistant Depression Review on the efficacy of various biological treatments, specifically in major depression resistant to cyclic antidepressantsInternational Clinical Psychopharmacology, 1989
- Results of an Open Clinical Trial of Brofaromine (CGP 11 305 A), a Competitive, Selective, and Short-Acting Inhibitor of MAO-A in Major Endogenous DepressionPharmacopsychiatry, 1987
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960